Award
NIH Reporter #11126972
Mitigating Diabetic Ketoacidosis in People with T1D and Chronic Kidney Disease on an SGLT1&2 Inhibitor: Ketosis Risk Factor Determination and Incorporation into an Enhanced Glucose Ketone Report
Recipient
Not Specified
Award Amount
$2,352,906.00
Ceiling
$2,352,906.00
Awarded
August 22, 2025
Identifier
11126972
NIH awarded a project to develop a risk mitigation strategy for diabetic ketoacidosis in patients with type 1 diabetes and chronic kidney disease using SGLT1&2 inhibitors, incorporating continuous ketone monitoring and enhanced glucose ketone reporting.
Description
This NIH project focuses on developing and evaluating a DKA risk mitigation strategy for the safe use of SGLT2 inhibitors in patients with T1D and CKD, leveraging continuous ketone monitoring and standardized CGM/CKM reports.